Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2006; 12(1): 94-98
Published online Jan 7, 2006. doi: 10.3748/wjg.v12.i1.94
Published online Jan 7, 2006. doi: 10.3748/wjg.v12.i1.94
Table 2 Correlation of L1 expression with WHO classification
| WHO classification | L1-negative | L1-positive | Total |
| Well-differentiated neuroendocrine tumors and Well-differentiated neuroendocrine carcinomas (grade 1a and 1b) | 53 | 1 | 54 |
| Poorly-differentiated neuroendocrine carcinomas (grade 2) | 5 | 4 | 9 |
| Total | 58 | 5 | 63 |
- Citation: Kaifi JT, Zinnkann U, Yekebas EF, Schurr PG, Reichelt U, Wachowiak R, Fiegel HC, Petri S, Schachner M, Izbicki JR. L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma. World J Gastroenterol 2006; 12(1): 94-98
- URL: https://www.wjgnet.com/1007-9327/full/v12/i1/94.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i1.94